Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age Over 18”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05364047
What this trial is testing

Clinical Trial of SARS-CoV-2 mRNA Vaccine in China

Who this might be right for
COVID-19
AIM Vaccine Co., Ltd. 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548127
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Who this might be right for
Breast Cancer
Pfizer 37
Not applicableStudy completedNCT03073447
What this trial is testing

WAMIF : Young Women Presenting Acute Myocardial Infarction in France

Who this might be right for
Acute Myocardial InfarctionWomen Over 18 and Under 50 Years of Age
French Cardiology Society 324
Early research (Phase 1)Study completedNCT01431664
What this trial is testing

AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Cancer Research UK 7
Early research (Phase 1)Study completedNCT06702462
What this trial is testing

Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

Who this might be right for
Asthma
GlaxoSmithKline 20
Testing effectiveness (Phase 2)UnknownNCT04748471
What this trial is testing

Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)

Who this might be right for
Prevention of COVID19
Assistance Publique - Hôpitaux de Paris 180
Not applicableEnded earlyNCT04516538
What this trial is testing

Effects of Mode of Contraction on Neuromuscular Fatigue

Who this might be right for
Volunteers
Centre Hospitalier Universitaire de Saint Etienne 65
Large-scale testing (Phase 3)Study completedNCT00380211
What this trial is testing

Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults

Who this might be right for
Influenza
GlaxoSmithKline 660
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableStudy completedNCT02211326
What this trial is testing

Genotype-guided Warfarin Individualized Treatment

Who this might be right for
Atrial FibrillationDeep Venous Thrombosis
The Third Xiangya Hospital of Central South University 660
Large-scale testing (Phase 3)Study completedNCT00929331
What this trial is testing

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Who this might be right for
Influenza, Human
GlaxoSmithKline 110
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Not applicableUnknownNCT00687921
What this trial is testing

F18-Flouride PET/CT in Acute Knee Injury

Who this might be right for
Knee Injury
Tel-Aviv Sourasky Medical Center 50
Not applicableNot Yet RecruitingNCT07412405
What this trial is testing

This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

Who this might be right for
Adult B-cell Acute Lymphoblastic LeukemiaFollicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)+2 more
GUSTAVO SALGUERO 12
Not applicableStudy completedNCT01007201
What this trial is testing

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population

Who this might be right for
Influenza
Adimmune Corporation 183
Testing effectiveness (Phase 2)Study completedNCT00592098
What this trial is testing

2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.

Who this might be right for
Amputation StumpsPain
SantoSolve AS 22
Early research (Phase 1)Study completedNCT06123663
What this trial is testing

Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Who this might be right for
Tetanus
CanSino Biologics Inc. 60
Not applicableStudy completedNCT03900039
What this trial is testing

An Assessment of 4 Different Bearing Types in Hip Replacement Types to Analsye the Lowest Wear Rates of Polyethylene

Who this might be right for
Arthroplasty ComplicationsHip Arthritis
Unity Health Toronto 100
Large-scale testing (Phase 3)WithdrawnNCT04806529
What this trial is testing

An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older

Who this might be right for
Influenza
Seqirus
Not applicableUnknownNCT05547256
What this trial is testing

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 54
Next Page